| Combined conventional/antioxidant "Astaxanthin" treatment for male infertility: a double blind, randomized trial 2005 · Astaxanthin group · Men with infertility of at least 2 months whose female partners had no demonstrable cause of infertility | 16 mg | 90 days | 11 |
| Astaxanthin improves assisted reproductive technology outcomes in poor ovarian responders through alleviating oxidative stress, inflammation, and apoptosis: a randomized clinical trial 2024 · AST group · Women older than 35 years with poor ovarian reserve and POSEIDON Group 4 poor ovarian response undergoing ART | 12 mg | 8 weeks | 30 |
| The effect of astaxanthin supplementation on performance and fat oxidation during a 40 km cycling time trial 2021 · astaxanthin condition · Recreationally trained male cyclists; ages and health condition not reported | 12 mg | 7 days | 12 |
| Efficacy of the natural antioxidant astaxanthin in the treatment of functional dyspepsia in patients with or without Helicobacter pylori infection: A prospective, randomized, double blind, and placebo-controlled study 2008 · 16mg astaxanthin · Patients with functional dyspepsia, with or without Helicobacter pylori infection | 16 mg | 4 weeks | 44 |
| Astaxanthin supplement improves clinical outcomes, quality of life, and inflammatory factors in patients with rheumatoid arthritis: a randomized clinical trial 2025 · astaxanthin intervention group · patients with rheumatoid arthritis; age and sex not specified | 20 mg | 8 weeks | 30 |
| Astaxanthin supplementation enhances metabolic adaptation with aerobic training in the elderly 2021 · AX group · Healthy adults aged 65–82 years, male and female, without serious chronic conditions | 12 mg | 120 days | 22 |
| Astaxanthin Supplemented with High-Intensity Functional Training Decreases Adipokines Levels and Cardiovascular Risk Factors in Men with Obesity 2023 · Supplement group (SG) · Men with obesity (BMI >30 kg/m²), mean age 27.6 years; not regularly physically active during the prior six months and without endocrine, metabolic or cardiovascular disease | 20 mg | 12 weeks | 15 |
| Astaxanthin Supplemented with High-Intensity Functional Training Decreases Adipokines Levels and Cardiovascular Risk Factors in Men with Obesity 2023 · Training + supplement group (TSG) · Men with obesity (BMI >30 kg/m²), mean age 27.6 years; not regularly physically active during the prior six months and without endocrine, metabolic or cardiovascular disease | 20 mg | 12 weeks | 15 |
| Efficacy of the natural antioxidant astaxanthin in the treatment of functional dyspepsia in patients with or without Helicobacter pylori infection: A prospective, randomized, double blind, and placebo-controlled study 2008 · 40mg astaxanthin · Patients with functional dyspepsia, with or without Helicobacter pylori infection | 40 mg | 4 weeks | 44 |
| The effectiveness of a standardized rose hip powder, containing seeds and shells of Rosa canina, on cell longevity, skin wrinkles, moisture, and elasticity 2015 · Astaxanthin group (skin study) · Healthy men and women aged 35–65 with well-defined crow’s-feet or other facial wrinkles | 4 mg | 8 weeks | 17 |
| The Protective Role of Astaxanthin for UV-Induced Skin Deterioration in Healthy People-A Randomized, Double-Blind, Placebo-Controlled Trial 2018 · astaxanthin group · Healthy Japanese adults aged 30 to 56 years; 21 females and 2 males enrolled across the study | 4 mg | 9 weeks | 12 |
| Effect of astaxanthin on cycling time trial performance 2011 · AST group · Competitive cyclists; age and sex not reported | 4 mg | 4 weeks | 7 |
| Astaxanthin (AstaReal(®)) Improved Acute and Chronic Digital Eye Strain in Children: A Randomized Double-Blind Placebo-Controlled Trial 2025 · astaxanthin group · Children aged 10–14 years with mild to moderate computer vision syndrome and at least 4 hours of daily screen time | 4 mg | 12 weeks | — |
| A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of a Krill Oil, Astaxanthin, and Oral Hyaluronic Acid Complex on Joint Health in People with Mild Osteoarthritis 2023 · FP-MD · Korean men and women aged 30–75 with mild knee or hip osteoarthritis (Kellgren–Lawrence Grade I or II) and K-VAS score ≥30 mm | 2 mg | 12 weeks | 50 |
| A randomized interventional clinical trial assessing the safety and effectiveness of PeaNoc XL tablets in managing joint pain and inflammation in arthritis patients 2023 · Group B: Standard Therapy + PeaNoc XL · Adults aged 18–60, any sex, with arthritis and DAS 28 score ≥3.2, experiencing joint pain and inflammation | 1 mg | 12 weeks | 35 |
| Effects of Astaxanthin, Lutein, and Zeaxanthin on Eye-Hand Coordination and Smooth-Pursuit Eye Movement after Visual Display Terminal Operation in Healthy Subjects: A Randomized, Double-Blind Placebo-Controlled Intergroup Trial 2023 · active group · Healthy Japanese males and females aged 20–60 years who routinely used visual display terminals or played video games | 6 mg | 8 weeks | 32 |
| Effects of Dietary Supplementation of Astaxanthin and Sesamin on Daily Fatigue: A Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Study 2018 · AS supplementation · Healthy men and women aged 30–60 years with total CFQ scores ≥21 | 6 mg | 4 weeks | 24 |
| Effects of Composite Supplement Containing Astaxanthin and Sesamin on Cognitive Functions in People with Mild Cognitive Impairment: A Randomized, Double-Blind, Placebo-Controlled Trial 2018 · AS group · Adults aged 57–78 with mild cognitive impairment; 50–79 years old were eligible | 6 mg | 12 weeks | 10 |
| Supplementating with dietary astaxanthin combined with collagen hydrolysate improves facial elasticity and decreases matrix metalloproteinase-1 and -12 expression: a comparative study with placebo 2014 · astaxanthin combined with collagen hydrolysate · healthy subjects with moderately photoaged skin | 2 mg | 12 weeks | — |
| An Examination into the Effects of a Nutraceutical Supplement on Cognition, Stress, Eye Health, and Skin Satisfaction in Adults with Self-Reported Cognitive Complaints: A Randomized, Double-Blind, Placebo-Controlled Trial 2024 · nutraceutical group · Healthy males and females aged 40–75 with self-reported memory complaints | 9 mg | 12 weeks | — |
| Antioxidant effect of astaxanthin on phospholipid peroxidation in human erythrocytes 2011 · 12 mg astaxanthin group · Middle-aged and senior subjects | 12 mg | 12 weeks | — |
| Benefits of Krill Oil Supplementation During Alternate-Day Fasting in Adults With Overweight and Obesity: A Randomized Trial 2025 · KO group · Healthy adults aged 25–65 with BMI >25 kg/m² and overweight or obesity; 25 women and 16 men enrolled | 200 mcg | 12 weeks | 21 |
| Carotenoids and antioxidants in age-related maculopathy italian study: multifocal electroretinogram modifications after 1 year 2008 · treated AMD (T-AMD) group · Patients with nonadvanced age-related macular degeneration; mean age 69.4 years | 4 mg | 1 year | 15 |
| Carotenoids in Age-related Maculopathy Italian Study (CARMIS): two-year results of a randomized study 2012 · treated group · Patients with age-related macular degeneration; age and sex not stated | 4 mg | 2 years | — |
| Astaxanthin treatment ameliorates ER stress in polycystic ovary syndrome patients: a randomized clinical trial 2023 · ASX group · Infertile women aged 18–40 years with PCOS meeting Rotterdam criteria and undergoing ICSI | 12 mg | 60 days | 27 |
| Impact of astaxanthin supplementation on markers of cardiometabolic health and tactical performance among firefighters 2024 · Astaxanthin (AX) · Healthy male career firefighters aged 24–48 years | 12 mg | 4 weeks | 15 |
| Administration of natural astaxanthin increases serum HDL-cholesterol and adiponectin in subjects with mild hyperlipidemia 2010 · 12 mg/day astaxanthin · Non-obese adults aged 25–60 years with fasting serum triglycerides of 120–200 mg/dL, without diabetes or hypertension | 12 mg | 12 weeks | — |
| Astaxanthin increases choroidal blood flow velocity 2012 · AXT · Healthy volunteers | 12 mg | 4 weeks | — |
| The Beneficial Effects of Astaxanthin on Glucose Metabolism and Modified Low-Density Lipoprotein in Healthy Volunteers and Subjects with Prediabetes 2021 · ASTX group · Adults aged 20–74, including healthy volunteers and subjects with prediabetes | 12 mg | 12 weeks | — |
| Astaxanthin supplementation impact on insulin resistance, lipid profile, blood pressure, and oxidative stress in polycystic ovary syndrome patients: A triple-blind randomized clinical trial 2024 · ASX · Infertile women with diagnosed polycystic ovary syndrome | 12 mg | 8 weeks | — |
| Comparative Pharmacokinetic Study of Standard Astaxanthin and its Micellar Formulation in Healthy Male Volunteers 2024 · Micellar astaxanthin (NovaSOL test) · Healthy men aged 18–45 years | 8 mg | 1 day | 12 |
| Comparative Pharmacokinetic Study of Standard Astaxanthin and its Micellar Formulation in Healthy Male Volunteers 2024 · Native astaxanthin reference · Healthy men aged 18–45 years | 8 mg | 1 day | 12 |
| Markers of Hypoxia and Oxidative Stress in Aging Volunteers Ingesting Lycosomal Formulation of Dark Chocolate Containing Astaxanthin 2018 · Group 2. ASTX alone · Men and women aged 60–70 with markers of inflammation and oxidation | 7 mg | 4 weeks | 8 |
| Markers of Hypoxia and Oxidative Stress in Aging Volunteers Ingesting Lycosomal Formulation of Dark Chocolate Containing Astaxanthin 2018 · Group 3. Co-ingestion ASTX+DC · Men and women aged 60–70 with markers of inflammation and oxidation | 7 mg | 4 weeks | 8 |
| Markers of Hypoxia and Oxidative Stress in Aging Volunteers Ingesting Lycosomal Formulation of Dark Chocolate Containing Astaxanthin 2018 · Group 4. Lycosome Formulation ASTX and DC (Esthechoc group) · Men and women aged 60–70 with markers of inflammation and oxidation | 7 mg | 4 weeks | 8 |
| Antioxidant effect of astaxanthin on phospholipid peroxidation in human erythrocytes 2011 · 6 mg astaxanthin group · Middle-aged and senior subjects | 6 mg | 12 weeks | — |
| Impact of astaxanthin on oxidative markers, uric acid, and clinical symptoms in heart failure: a randomized clinical trial 2025 · intervention group (ASX) · Adults aged 18 years or older with stage C or D heart failure and left ventricular ejection fraction below 50% | 20 mg | 60 days | 40 |
| Astaxanthin ameliorates inflammation, oxidative stress, and reproductive outcomes in endometriosis patients undergoing assisted reproduction: A randomized, triple-blind placebo-controlled clinical trial 2023 · AST (astaxanthin) group · Women aged 20–40 with infertility caused by stage III/IV endometriosis undergoing assisted reproduction | 6 mg | 12 weeks | 25 |
| The antioxidant and anti-inflammatory effects of astaxanthin supplementation on the expression of miR-146a and miR-126 in patients with type 2 diabetes mellitus: A randomised, double-blind, placebo-controlled clinical trial 2021 · AST · Patients with type 2 diabetes mellitus; age range and sex not stated | 8 mg | 8 weeks | 22 |
| Boosting Antioxidant Defense: The Effect of Astaxantin on Superoxidase Dismutase and Malondialdehyde Reduction in Patients with Head and Neck Cancer Receiving Cisplatin Chemotherapy 2024 · Astaxanthin group · Patients aged over 11 and under 80 with stage II–IV head and neck cancer receiving cisplatin chemotherapy; males and females | 8 mg | 3 weeks | 21 |
| Redox-sensitive miRNAs and Humanin could mediate effects of exercise and astaxanthin on oxidative stress and inflammation in type 2 diabetes 2025 · AST supplementation (S) · Women aged 30–60 years with type 2 diabetes mellitus, not using insulin | 8 mg | 8 weeks | 15 |
| Redox-sensitive miRNAs and Humanin could mediate effects of exercise and astaxanthin on oxidative stress and inflammation in type 2 diabetes 2025 · Combined training + AST supplementation (CT + S) · Women aged 30–60 years with type 2 diabetes mellitus, not using insulin | 8 mg | 8 weeks | 15 |
| Astaxanthin Supplementation Increases Glutathione Concentrations but Does Not Impact Fat Oxidation During Exercise in Active Young Men 2022 · astaxanthin · Active men aged 23 ± 2 years | 6 mg | 4 weeks | 14 |
| Protective effects of Haematococcus astaxanthin on oxidative stress in healthy smokers 2011 · 20 mg group · Heavy smokers (at least 20 cigarettes per day); age and sex not reported | 20 mg | 3 weeks | 13 |
| Exploring the Impact of Astaxanthin Supplementation in Conjunction with a 12-Week CrossFit Training Regimen on Selected Adipo-Myokines Levels in Obese Males 2024 · supplement group (SG) · Obese males; mean age of the study sample was 27.6 years | 20 mg | 12 weeks | 11 |
| Exploring the Impact of Astaxanthin Supplementation in Conjunction with a 12-Week CrossFit Training Regimen on Selected Adipo-Myokines Levels in Obese Males 2024 · training + supplement group (TSG) · Obese males; mean age of the study sample was 27.6 years | 20 mg | 12 weeks | 11 |
| Administration of natural astaxanthin increases serum HDL-cholesterol and adiponectin in subjects with mild hyperlipidemia 2010 · 6 mg/day astaxanthin · Non-obese adults aged 25–60 years with fasting serum triglycerides of 120–200 mg/dL, without diabetes or hypertension | 6 mg | 12 weeks | — |
| Administration of natural astaxanthin increases serum HDL-cholesterol and adiponectin in subjects with mild hyperlipidemia 2010 · 18 mg/day astaxanthin · Non-obese adults aged 25–60 years with fasting serum triglycerides of 120–200 mg/dL, without diabetes or hypertension | 18 mg | 12 weeks | — |
| Effects of astaxanthin on oxidative stress in overweight and obese adults 2011 · ASX 20 mg · Adults in Korea with BMI > 25.0 kg/m² who were overweight or obese | 20 mg | 3 weeks | — |
| Astaxanthin improves glucose metabolism and reduces blood pressure in patients with type 2 diabetes mellitus 2018 · astaxanthin supplementation · Participants with type 2 diabetes mellitus | 8 mg | 8 weeks | — |
| Randomized controlled trial of astaxanthin impacts on antioxidant status and assisted reproductive technology outcomes in women with polycystic ovarian syndrome 2022 · intervention group · Women with polycystic ovary syndrome (PCOS) | 8 mg | 40 days | — |
| Astaxanthin treatment decreases pro-inflammatory cytokines and improves reproductive outcomes in patients with polycystic ovary syndrome undergoing assisted reproductive technology: A randomized clinical trial 2024 · intervention group · Infertile patients with polycystic ovary syndrome undergoing assisted reproductive technology; age and sex details not reported | 6 mg | 8 weeks | — |
| Plasma carotenoid concentrations before and after supplementation with astaxanthin in middle-aged and senior subjects 2011 · 1 mg/d group · Japanese middle-aged and senior subjects | 1 mg | 4 weeks | 10 |
| Plasma carotenoid concentrations before and after supplementation with astaxanthin in middle-aged and senior subjects 2011 · 3 mg/d group · Japanese middle-aged and senior subjects | 3 mg | 12 weeks | 10 |
| Protective effects of Haematococcus astaxanthin on oxidative stress in healthy smokers 2011 · 5 mg group · Heavy smokers (at least 20 cigarettes per day); age and sex not reported | 5 mg | 3 weeks | 13 |
| Protective effects of Haematococcus astaxanthin on oxidative stress in healthy smokers 2011 · 40 mg group · Heavy smokers (at least 20 cigarettes per day); age and sex not reported | 40 mg | 3 weeks | 13 |
| Effects of astaxanthin on oxidative stress in overweight and obese adults 2011 · ASX 5 mg · Adults in Korea with BMI > 25.0 kg/m² who were overweight or obese | 5 mg | 3 weeks | — |
| Safety and lipid-altering efficacy of a new omega-3 fatty acid and antioxidant-containing medical food in men and women with elevated triacylglycerols 2015 · PDL-0101 · Adults with triacylglycerols 150–499 mg/dL and LDL cholesterol ≥70 mg/dL | 12 mg | 8 weeks | — |
| Effects of a New Combination of Medical Food on Endothelial Function and Lipid Profile in Dyslipidemic Subjects: A Pilot Randomized Trial 2019 · Nutraceutical B · Adults aged 18–75 with elevated serum cholesterol not requiring statins or statin-intolerant; people with cardiovascular disease and uncontrolled diabetes were excluded. | 500 mcg | 6 weeks | 23 |